CRDF
Cardiff Oncology, Inc. Common StockData: 2026-09-04
Quick Stats
Sep 04, 202636.5
AI Score
EXTENDED0.56
Volume Ratio
TBA
Next Earnings
19
+ve Days (30d)
11
-ve Days (30d)
CRDF Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
CRDF Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
CRDF Options - Sort by Max open Interest (near term)
5th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CRDF Daily Out of Money Options - Sort by Max open Interest (near term)
5th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CRDF Daily In the Money Options - Sort by Max open Interest (near term)
5th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CRDF Most Active Options by Volume(near term)
5th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CRDF Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CRDF Stock Summary
Last updated Sep 04, 2026
CRDF is currently trading at $1.09, positioned below its 200-day moving average of $1.72, suggesting bearish momentum. The stock has a 52-week range of $0.7566 to $3.31.
Technical Analysis: The 50-day moving average stands at $1.02, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 59.756, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.095, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CRDF at 36.5/100 with a EXTENDED recommendation.
CRDF (Cardiff Oncology, Inc. Common Stock) Indicators
Last updated Sep 04, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 59.756 |
| CMF (20) | -0.095 |
| ROC (10) | 23.85 |
| ADX (14) | 20.257 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.014 |
| AROONOSC (14) | 92.857 |
| WILLAMS %R (14) | -4.293 |
| MFI (14) | 76.088 |
Cardiff Oncology, Inc. Common Stock is above the 50 Day SMA but below the 200 Day SMA — short-term strength within a longer-term downtrend (Mixed).
CRDF Moving Averages Analysis
Cardiff Oncology, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Sep 04, 2026
CRDF (Cardiff Oncology, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Sep 04, 2026
| Days | MA |
|---|---|
| 10 | 1.02 |
| 20 | 0.98 |
| 30 | 0.95 |
| 50 | 1.02 |
| 100 | 1.31 |
| 200 | 1.72 |
CRDF Fundamental Analysis
| P/E (Forward) | -- |
| P/E (Trailing) | -- |
| Market Cap ($) | 84.0 million |
| Earnings/Share ($) | -0.61 |
| Net Profit Margin (%) | -- |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.5625 |
| EPS Estimate Next Year ($) | -0.6033 |
| WallStreet Target Price ($) | 5.28 |
| Most Recent Quarter |
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.